Alwin Schuller

Alwin Schuller is a Senior Principal Scientist at AstraZeneca, where they mentor a team of oncology pharmacologists and lead projects in immuno-oncology. Prior to this role, Alwin served as a Senior Research Scientist at Wyeth Research, focusing on signal transduction pathways for drug target discovery. Alwin also held positions at Millennium Pharmaceuticals, Novartis, and Merck, managing teams and providing preclinical pharmacology support for oncology projects. They completed their PhD in IGF binding proteins from Erasmus Universiteit Rotterdam and hold a Bachelor of Science in Neuroscience from Universiteit Utrecht.